In addition, higher expression of OGT, FOXC1, ASNS, GPT2, CBS, or FTH1 was also associated with poorer outcomes in clinical cases with renal clear cell carcinoma or glioma (Fig. S12). This evidence concerns the gene FTH1 and glioma.